UVB and Psoriasis: More Than Immunosuppression
UVB's benefits may run deeper than inflammation suppression—cholesterol metabolism could be a key link.
By
Kerri Miller
April 6, 2026
Clinical Scorecard: UVB and Psoriasis: More Than Immunosuppression
At a Glance
Category Detail
Condition Psoriasis Key Mechanisms Cholesterol synthesis, ROR-gamma signaling, IL-17 regulation Target Population Patients with psoriasis Care Setting Dermatology
Key Highlights
UVB phototherapy may disrupt cholesterol synthesis and ROR-gamma signaling. Cholesterol precursors can be converted into vitamin D3 and derivatives that inhibit inflammation. Proposed mechanisms suggest anti-inflammatory effects beyond immunosuppression. Noncalcemic vitamin D metabolites are potential therapeutic candidates. Further validation of lumisterol and tachysterol derivatives is needed. Guideline-Based Recommendations
Diagnosis
Consider psoriasis in patients with inflammatory skin lesions. Management
Utilize UVB phototherapy as a treatment option for psoriasis. Monitoring & Follow-up
Assess patient response to UVB therapy and adjust as necessary. Risks
Monitor for potential side effects of UVB exposure and vitamin D metabolites. Patient & Prescribing Data
Individuals diagnosed with psoriasis.
Emerging therapies may target cholesterol metabolism and ROR-gamma signaling.
Clinical Best Practices
Incorporate UVB phototherapy in treatment plans for psoriasis. Evaluate the role of cholesterol metabolism in psoriatic inflammation. Consider noncalcemic vitamin D derivatives in therapeutic strategies. Related Resources & Content
